Drug Shortage Report for DEPO-PROVERA

Last updated on 2021-04-09 History

Report ID	131486
Drug Identification Number	00585092
Brand name	DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name	DEPO-PROVERA
Company Name	PFIZER CANADA ULC
Market Status	MARKETED
Active Ingredient(s)	MEDROXYPROGESTERONE ACETATE
Strength(s)	150MG
Dosage form(s)	SUSPENSION
Route of administration	INTRAMUSCULAR INTRAMUSCULAR
Packaging size	1 x 1ML
ATC code	G03AC
ATC description	HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage	Disruption of the manufacture of the drug.
Anticipated start date	2021-07-01
Actual start date
Estimated end date	2022-06-01
Actual end date
Shortage status	Anticipated shortage
Updated date	2021-04-09
Company comments	Available inventory is currently on preventative allocation. Pfizer worked in collaboration with Health Canada and has received their authorization to import a batch of foreign-labelled supply of DEPO-PROVERA pre-filled syringes from the United States. Pfizer is committed to prioritize access to DEPO-PROVERA and is working diligently to have this alternate supply available in time to bridge the gap and mitigate any supply challenge with the product in 2021.
Health Canada comments
Contact Address	17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5
Company contact information	Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.